← back to search

Hao Deng

Guangzhou University of Chinese Medicine · CN
🔎 Find collaborators in Immunology · Dermatology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Immunology · Dermatology
Research interest
Research interests include Psoriasis, Medicine, microRNA, Randomized controlled trial, Blood stasis, and Psoriasis Area and Severity Index.
h-index
citations
209
works
27
NIH funding
primary concept
email

Recent publications

Chinese herbal medicine (Guben Qushi Huayu formula) combined with Ixekizumab in reducing psoriasis vulgaris relapse: Protocol for a mixed-methods research study
Frontiers in Pharmacology 2025cited by 1position: middledoi
Exploring therapeutic mechanism of Fuzhenghefuzhiyang Formula in psoriasis: inflammation and metabolism regulation
Frontiers in Immunology 2025cited by 0position: middledoi
The Benefit of the Optimized Formula of Yinxieling in Psoriasis Vulgaris via Regulation on Autophagy Based on microRNA Expression Profile and Network Pharmacology Analysis
Drug Design Development and Therapy 2024cited by 6position: middledoi
Systematic analysis of serum peptidase inhibitor 3 in psoriasis diagnosis and treatment
Clinical Rheumatology 2024cited by 3position: middledoi
Increased Abnormal Erythrocytes Caused by Spleen Filtration Deficiency Provide a Hypoxic Environment for the Occurrence of Psoriasis
Experimental Dermatology 2024cited by 1position: middledoi
Add-on effects of Chinese herbal medicine external application (FZHFZY) to topical urea for mild-to-moderate psoriasis vulgaris: Protocol for a double-blinded randomized controlled pilot trial embedded with a qualitative study
PLoS ONE 2024cited by 1position: middledoi
Metabolic rewiring in keratinocytes by miR‐31‐5p identifies therapeutic intervention for psoriasis
EMBO Molecular Medicine 2023cited by 21position: middledoi
Analysis of the potential pyroptosis mechanism in psoriasis and experimental validation of NLRP3 in vitro and in vivo
International Immunopharmacology 2023cited by 18position: middledoi
Potential biomarkers for psoriasis topical treatment by in-depth serum proteomics
Journal of Dermatological Treatment 2023cited by 8position: middledoi
Deciphering the mechanism of PSORI-CM02 in suppressing keratinocyte proliferation through the mTOR/HK2/glycolysis axis
Frontiers in Pharmacology 2023cited by 5position: middledoi
Noni (<i>Morinda citrifolia</i> L.) Fruit Polysaccharide Attenuated Inflammatory Bowel Disease Mice: Association of STAT3/NLRP3 Signaling Pathways
ACS Food Science & Technology 2023cited by 1position: middledoi
Corrigendum: Deep sequencing of plasma exosomal microRNA level in psoriasis vulgaris patients
Frontiers in Medicine 2023cited by 0position: middledoi
P. granatum Peel Polysaccharides Ameliorate Imiquimod-Induced Psoriasis-Like Dermatitis in Mice via Suppression of NF-κB and STAT3 Pathways
Frontiers in Pharmacology 2022cited by 21position: middledoi
Association of the characteristics of the blood metabolome and gut microbiome with the outcome of methotrexate therapy in psoriasis
Frontiers in Immunology 2022cited by 13position: middledoi
Deep Sequencing of Plasma Exosomal microRNA Level in Psoriasis Vulgaris Patients
Frontiers in Medicine 2022cited by 10position: middledoi
The Gene Expression Analysis of Peripheral Blood Monocytes From Psoriasis Vulgaris Patients With Different Traditional Chinese Medicine Syndromes
Frontiers in Pharmacology 2022cited by 6position: middledoi
Hsa-miR-31-5p controls a metabolic switch in psoriatic keratinocytes that identifies therapeutic intervention
bioRxiv (Cold Spring Harbor Laboratory) 2022cited by 2position: middledoi
Increased abnormal erythrocytes caused by spleen filtration deficiency provide a hypoxic environment for the occurrence of psoriasis
Research Square 2022cited by 0position: middledoi
Adipose-derived mesenchymal stem cells (AD-MSCs) in the treatment for psoriasis: results of a single-arm pilot trial
Annals of Translational Medicine 2021cited by 27position: middledoi
Add‐on effect of PSORI‐CM01 to topical calcipotriol for moderate psoriasis vulgaris: A multi‐center, randomized, double‐blind pilot study
Clinical and Translational Medicine 2021cited by 18position: middledoi
Comparison of PSORI-CM01 granules and Yinxieling tablets for patients with chronic plaque psoriasis: a pilot study for a randomized, double-blinded, double-dummy, multicentre trial
Annals of Palliative Medicine 2021cited by 13position: middledoi
Gene Expression of PSORI-CM01 and Yinxieling in the Treatment of Psoriasis Vulgaris
Evidence-based Complementary and Alternative Medicine 2021cited by 1position: middledoi
The protective effects of Fuzhengzhiyanghefuzhiyang decoction (FZHFZY) on imiquimod-induced psoriasis in mice through suppression of P38/Erk/NF-κB signaling
Research Square 2021cited by 0position: middledoi
Metabonomics Study on Serum Characteristic Metabolites of Psoriasis Vulgaris Patients With Blood-Stasis Syndrome
Frontiers in Pharmacology 2020cited by 16position: middledoi
Analysis of microRNA expression in peripheral blood monocytes of three Traditional Chinese Medicine (TCM) syndrome types in psoriasis patients
Chinese Medicine 2020cited by 9position: middledoi
Exploration of the Regulatory Effects of PSORI-CM01 and Yin Xie Ling on microRNAs in the Peripheral Blood Monocytes of Patients with Blood Stasis Syndrome of Psoriasis Vulgaris
Research Square 2020cited by 0position: middledoi
Auricular acupressure as a complementary therapy for psoriasis vulgaris: study protocol for a multicenter randomized controlled trial
Trials 2019cited by 8position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Chuanjian Lu · Guangzhou University of Chinese Medicine25 papers (2020–2025)Danni Yao · Guangzhou University of Chinese Medicine17 papers (2019–2025)Jingwen Deng · Utrecht University14 papers (2019–2025)Ling Han · Fudan University12 papers (2020–2024)Yuhong Yan · Guangzhou University of Chinese Medicine12 papers (2019–2025)Shuyan Ye · Guangzhou University of Chinese Medicine9 papers (2020–2025)Jingjie Yu · Guangzhou University of Chinese Medicine8 papers (2021–2025)Yue Lu · Guangzhou University of Chinese Medicine6 papers (2020–2024) · 5 papers (2020–2024)Haiming Chen · Guangzhou University of Chinese Medicine5 papers (2020–2025)Bin Tang · Guangzhou University of Chinese Medicine5 papers (2021–2025)Runyue Huang · Utrecht University5 papers (2022–2023)Qubo Chen · Guangzhou University of Chinese Medicine5 papers (2020–2024)Yao Qi · Shanxi Medical University5 papers (2020–2024)Maojie Wang · Utrecht University5 papers (2022–2023)Jianan Wei · Guangzhou University of Chinese Medicine4 papers (2020–2024)Haiming Chen · Guangzhou University of Chinese Medicine3 papers (2021–2023)Haiming Chen · Guangzhou University of Chinese Medicine3 papers (2024–2025)Li Li · Hebei Medical University3 papers (2020–2022)Boudewijn Burgering · The Netherlands Cancer Institute3 papers (2022–2023)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Immunology · Dermatology →